2018-2025 Klebsiella Pneumoniae Infection Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

March 2018 | 126 pages | ID: 2389107B4AFEN
QYResearch

Abstracts

SUMMARY

This report studies the Klebsiella Pneumoniae Infection Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Klebsiella Pneumoniae Infection Drug market by product type and application/end industries.

The global Klebsiella Pneumoniae Infection Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Klebsiella Pneumoniae Infection Drug.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Klebsiella Pneumoniae Infection Drug in these regions, from 2013 to 2025 (forecast), covering

• United States
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The major players in global and United States market, including

• Acies Bio doo
• Appili Therapeutics
• Debiopharm International SA
• Evaxion Biotech ApS
• F. Hoffmann-La Roche Ltd
• FOB Synthesis Inc
• ImmunoClin Corp
• Innovation Pharmaceuticals Inc
• Kyorin Pharmaceutical Co Ltd
• Melinta Therapeutics Inc
• Nosopharm SAS
• Peptilogics Inc
• Pfizer Inc
• Phico Therapeutics Ltd
• Sarepta Therapeutics Inc
• Shionogi & Co Ltd
• Syntiron LLC
• Tetraphase Pharmaceuticals Inc

On the basis of product, the market is primarily split into

• ATI-1503
• CA-824
• CC-1807
• Cefiderocol
• Debio-1454
• EBX-004
• Others

On the basis on the end users/application, this report covers

• Hospital
• Clinic
• Others

Contents

2018-2025 KLEBSIELLA PNEUMONIAE INFECTION DRUG REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 KLEBSIELLA PNEUMONIAE INFECTION DRUG MARKET OVERVIEW

2.1 Klebsiella Pneumoniae Infection Drug Product Overview
2.2 Klebsiella Pneumoniae Infection Drug Market Segment by Type
  2.2.1 ATI-1503
  2.2.2 CA-824
  2.2.3 CC-1807
  2.2.4 Cefiderocol
  2.2.5 Debio-1454
  2.2.6 EBX-004
  2.2.7 Others
2.3 Global Klebsiella Pneumoniae Infection Drug Product Segment by Type
  2.3.1 Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Type (2013-2018)
2.4 United States Klebsiella Pneumoniae Infection Drug Product Segment by Type
  2.4.1 United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share by Type (2013-2018)
  2.4.3 United States Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Type (2013-2018)

3 KLEBSIELLA PNEUMONIAE INFECTION DRUG APPLICATION/END USERS

3.1 Klebsiella Pneumoniae Infection Drug Segment by Application/End Users
  3.1.1 Hospital
  3.1.2 Clinic
  3.1.3 Others
3.2 Global Klebsiella Pneumoniae Infection Drug Product Segment by Application
  3.2.1 Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Klebsiella Pneumoniae Infection Drug Product Segment by Application
  3.3.1 United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 KLEBSIELLA PNEUMONIAE INFECTION DRUG MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Klebsiella Pneumoniae Infection Drug Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Klebsiella Pneumoniae Infection Drug Sales and Revenue by Regions
  4.2.1 Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.4 North America Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.7 South America Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.9 United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Klebsiella Pneumoniae Infection Drug Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Klebsiella Pneumoniae Infection Drug Manufacturing Base Distribution, Sales Area, Product Types
5.5 Klebsiella Pneumoniae Infection Drug Market Competitive Situation and Trends
  5.5.1 Klebsiella Pneumoniae Infection Drug Market Concentration Rate
  5.5.2 Global Klebsiella Pneumoniae Infection Drug Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES KLEBSIELLA PNEUMONIAE INFECTION DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Klebsiella Pneumoniae Infection Drug Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Klebsiella Pneumoniae Infection Drug Market Share (%) of Top 3 and Top 5 Players

7 KLEBSIELLA PNEUMONIAE INFECTION DRUG PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Acies Bio doo
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
   7.1.2.1 Product A
   7.1.2.2 Product B
  7.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Appili Therapeutics
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
   7.2.2.1 Product A
   7.2.2.2 Product B
  7.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Debiopharm International SA
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
   7.3.2.1 Product A
   7.3.2.2 Product B
  7.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Evaxion Biotech ApS
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
   7.4.2.1 Product A
   7.4.2.2 Product B
  7.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 F. Hoffmann-La Roche Ltd
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
   7.5.2.1 Product A
   7.5.2.2 Product B
  7.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 FOB Synthesis Inc
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
   7.6.2.1 Product A
   7.6.2.2 Product B
  7.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 ImmunoClin Corp
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
   7.7.2.1 Product A
   7.7.2.2 Product B
  7.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Innovation Pharmaceuticals Inc
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
   7.8.2.1 Product A
   7.8.2.2 Product B
  7.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Kyorin Pharmaceutical Co Ltd
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
   7.9.2.1 Product A
   7.9.2.2 Product B
  7.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Melinta Therapeutics Inc
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
   7.10.2.1 Product A
   7.10.2.2 Product B
  7.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.10.4 Main Business/Business Overview
7.11 Nosopharm SAS
7.12 Peptilogics Inc
7.13 Pfizer Inc
7.14 Phico Therapeutics Ltd
7.15 Sarepta Therapeutics Inc
7.16 Shionogi & Co Ltd
7.17 Syntiron LLC
7.18 Tetraphase Pharmaceuticals Inc

8 KLEBSIELLA PNEUMONIAE INFECTION DRUG MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Klebsiella Pneumoniae Infection Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL KLEBSIELLA PNEUMONIAE INFECTION DRUG MARKET FORECAST

10.1 Global Klebsiella Pneumoniae Infection Drug Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.1.2 Global Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Klebsiella Pneumoniae Infection Drug Market Forecast
  10.2.1 United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Klebsiella Pneumoniae Infection Drug Forecast by Regions
  10.3.1 North America Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Klebsiella Pneumoniae Infection Drug Forecast by Type
  10.4.1 Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Klebsiella Pneumoniae Infection Drug Forecast by Application
  10.5.1 Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Application (2018-2025)
  10.5.2 United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION



The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Klebsiella Pneumoniae Infection Drug Product Picture
Figure Global Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of ATI-1503
Table Major Players of ATI-1503
Figure Global ATI-1503 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of CA-824
Table Major Players of CA-824
Figure Global CA-824 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of CC-1807
Table Major Players of CC-1807
Figure Global CC-1807 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Cefiderocol
Table Major Players of Cefiderocol
Figure Global Cefiderocol Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Debio-1454
Table Major Players of Debio-1454
Figure Global Debio-1454 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of EBX-004
Table Major Players of EBX-004
Figure Global EBX-004 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Type (2013-2018)
Table Global Klebsiella Pneumoniae Infection Drug Sales Share (%) by Type (2013-2018)
Figure Global Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Type (2013-2018)
Figure Global Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Type in 2017
Table Global Klebsiella Pneumoniae Infection Drug Revenue (Million USD) by Type (2013-2018)
Table Global Klebsiella Pneumoniae Infection Drug Revenue Share (%) by Type (2013-2018)
Figure Global Klebsiella Pneumoniae Infection Drug Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Type
Table Global Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Type (2013-2018)
Table United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Type (2013-2018)
Table United States Klebsiella Pneumoniae Infection Drug Sales Share (%) by Type (2013-2018)
Figure United States Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Type (2013-2018)
Figure United States Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Type in 2017
Table United States Klebsiella Pneumoniae Infection Drug Revenue (Million USD) by Type (2013-2018)
Table United States Klebsiella Pneumoniae Infection Drug Revenue Share (%) by Type (2013-2018)
Figure United States Klebsiella Pneumoniae Infection Drug Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Type
Table United States Klebsiella Pneumoniae Infection Drug Price (USD/Pcs) by Type (2013-2018)
Figure Hospital Examples
Figure Clinic Examples
Figure Others Examples
Table Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Application (2013-2018)
Table Global Klebsiella Pneumoniae Infection Drug Sales Share (%) by Application (2013-2018)
Figure Global Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Application (2013-2018)
Figure Global Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Application in 2017
Table United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Application (2013-2018)
Table United States Klebsiella Pneumoniae Infection Drug Sales Share (%) by Application (2013-2018)
Figure United States Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Application (2013-2018)
Figure United States Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Application in 2017
Table Global Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Regions (2013-2018)
Table Global Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Regions (2013-2018)
Figure Global Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Regions
Figure 2017 United States Klebsiella Pneumoniae Infection Drug Sales Market Share (%) in Global Market
Table Global Klebsiella Pneumoniae Infection Drug Revenue (Million USD) by Regions (2013-2018)
Table Global Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Regions (2013-2018)
Figure Global Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Regions
Figure 2017 United States Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) in Global Market
Table Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) of Key Players (2013-2018)
Table Global Klebsiella Pneumoniae Infection Drug Sales Share (%) by Players (2013-2018)
Figure 2017 Global Klebsiella Pneumoniae Infection Drug Sales Share (%) by Players
Figure 2018 Global Klebsiella Pneumoniae Infection Drug Sales Share (%) by Players
Table Global Klebsiella Pneumoniae Infection Drug Revenue (Million USD) by Players (2013-2018)
Table Global Klebsiella Pneumoniae Infection Drug Revenue Share (%) by Players (2013-2018)
Table 2017 Global Klebsiella Pneumoniae Infection Drug Revenue Share (%) by Players
Table 2018 Global Klebsiella Pneumoniae Infection Drug Revenue Share (%) by Players
Table Global Market Klebsiella Pneumoniae Infection Drug Average Price (USD/Pcs) by Players (2013-2018)
Table Global Klebsiella Pneumoniae Infection Drug Top Players Manufacturing Base Distribution and Sales Area
Table Global Klebsiella Pneumoniae Infection Drug Top Players Product Category
Figure Global Klebsiella Pneumoniae Infection Drug Market Share (%) of Top 3 Players
Figure Global Klebsiella Pneumoniae Infection Drug Market Share (%) of Top 5 Players
Table United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) by Players (2013-2018)
Table United States Klebsiella Pneumoniae Infection Drug Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Klebsiella Pneumoniae Infection Drug Sales Share (%) by Players
Figure 2018 United States Klebsiella Pneumoniae Infection Drug Sales Share (%) by Players
Table United States Klebsiella Pneumoniae Infection Drug Revenue (Million USD) by Players (2013-2018)
Table United States Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Klebsiella Pneumoniae Infection Drug Revenue Share (%) by Players
Table 2018 United States Klebsiella Pneumoniae Infection Drug Revenue Share (%) by Players
Table United States Market Klebsiella Pneumoniae Infection Drug Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Klebsiella Pneumoniae Infection Drug Market Share (%) of Top 3 Players
Figure United States Klebsiella Pneumoniae Infection Drug Market Share (%) of Top 5 Players
Table Acies Bio doo Basic Information List
Table Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales Growth Rate (2013-2018)
Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales Global Market Share (%)(2013-2018)
Figure Acies Bio doo Klebsiella Pneumoniae Infection Drug Revenue Global Market Share (%)(2013-2018)
Table Appili Therapeutics Basic Information List
Table Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales Growth Rate (2013-2018)
Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales Global Market Share (%)(2013-2018)
Figure Appili Therapeutics Klebsiella Pneumoniae Infection Drug Revenue Global Market Share (%)(2013-2018)
Table Debiopharm International SA Basic Information List
Table Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales Growth Rate (2013-2018)
Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales Global Market Share (%)(2013-2018)
Figure Debiopharm International SA Klebsiella Pneumoniae Infection Drug Revenue Global Market Share (%)(2013-2018)
Table Evaxion Biotech ApS Basic Information List
Table Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales Growth Rate (2013-2018)
Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales Global Market Share (%)(2013-2018)
Figure Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Revenue Global Market Share (%)(2013-2018)
Table F. Hoffmann-La Roche Ltd Basic Information List
Table F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales Global Market Share (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Revenue Global Market Share (%)(2013-2018)
Table FOB Synthesis Inc Basic Information List
Table FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales Growth Rate (2013-2018)
Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales Global Market Share (%)(2013-2018)
Figure FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Revenue Global Market Share (%)(2013-2018)
Table ImmunoClin Corp Basic Information List
Table ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales Growth Rate (2013-2018)
Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales Global Market Share (%)(2013-2018)
Figure ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Revenue Global Market Share (%)(2013-2018)
Table Innovation Pharmaceuticals Inc Basic Information List
Table Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales Growth Rate (2013-2018)
Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales Global Market Share (%)(2013-2018)
Figure Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Revenue Global Market Share (%)(2013-2018)
Table Kyorin Pharmaceutical Co Ltd Basic Information List
Table Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales Growth Rate (2013-2018)
Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales Global Market Share (%)(2013-2018)
Figure Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Revenue Global Market Share (%)(2013-2018)
Table Melinta Therapeutics Inc Basic Information List
Table Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales Growth Rate (2013-2018)
Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales Global Market Share (%)(2013-2018)
Figure Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Revenue Global Market Share (%)(2013-2018)
Table Nosopharm SAS Basic Information List
Table Peptilogics Inc Basic Information List
Table Pfizer Inc Basic Information List
Table Phico Therapeutics Ltd Basic Information List
Table Sarepta Therapeutics Inc Basic Information List
Table Shionogi & Co Ltd Basic Information List
Table Syntiron LLC Basic Information List
Table Tetraphase Pharmaceuticals Inc Basic Information List
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Klebsiella Pneumoniae Infection Drug
Figure Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis
Table Major Buyers of Klebsiella Pneumoniae Infection Drug
Table Distributors/Traders List
Figure Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Klebsiella Pneumoniae Infection DrugKlebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Klebsiella Pneumoniae Infection Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Klebsiella Pneumoniae Infection Drug Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Klebsiella Pneumoniae Infection Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Klebsiella Pneumoniae Infection Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Klebsiella Pneumoniae Infection Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Klebsiella Pneumoniae Infection Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Klebsiella Pneumoniae Infection Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Klebsiella Pneumoniae Infection Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Klebsiella Pneumoniae Infection Drug Sales Forecast by Application (2018-2025)
Table United States Klebsiella Pneumoniae Infection Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Klebsiella Pneumoniae Infection Drug Sales Forecast by Application (2018-2025)